Starbucks is partnering with Ariana Grande on its latest coffee offering. The coffee chain and singer both posted twin cloud emoji tweets on Monday. Grande tagged @Starbucks, leading fans online to piece together that she was teasing the new "Cloud Macchiato," which Starbucks ($SBUX) officially launched this week. She followed those up with a pair of new tweets Tuesday morning showing the singer decked out in a Starbucks apron sipping on one of the new bevvies.
Internal documents showed that Grande was helping the company launch the new beverage, according to Business Insider.
Grande might already be considered an unofficial brand ambassador given how many times she's been snapped holding a Starbucks drink. Starbucks has not confirmed that it has a partnership with the "Thank U, Next" singer, though BI reported that as part of the promotion some stores will also feature Grande-approved playlists and songs.
The Cloud Macchiato is a twist on an Italian coffee staple. The "macchiato," literally translated to "stained" is a shot of espresso with a bit (stain) of frothed milk. Starbucks gained success bastardizing that and other Italian cafe classics with iced versions, caramel drizzles, and mocha. The Cloud version will come in cinnamon or caramel versions with a dollop of whipped cold milk foam, according to the press release.
Disney+ miss on new subscribers in Q3 and the growing momentum for moviegoers returning to brick-and-mortar theaters has brought the streaming business into question. Seth Schachner, managing director at Strat Americas, joined Cheddar to discuss the state of streaming and the growing number of options consumers have. "Streaming is for sure here to stay and I think more robust than ever," he said. "The real thing that's happening, not just to Hollywood but to lots of verticals from music to sports, is just that there's tons and tons of consumer choice."
Peter Weber, author and star of ABC's The Bachelor, joined Cheddar to talk about his new children's book, "The Adventures of Pilot Pete," scheduled for release on Nov. 23. Weber, a real commercial pilot, said that while fellow Bachelor Nation contestants tend to write books following their experience on the small screen, one of the reasons he opted to write a children's book instead was the prospect of the longevity it could provide.
Dr. Wendy Osefo, Entrepreneur, Professor & Cast Member of Bravo's 'Real Housewives of Potomac', joins 'Your Future Home' to discuss her popular new Onyi Home Essentials line and how ideas of family and legacy helped shape it.
David Girouard, CEO of Upstart, an artificial intelligence lending platform, joined Cheddar to discuss Q3 earnings, noting growth in revenue and profits as more banks, credit unions, and car dealerships use Upstart tech. He also reflected on how his fintech company is working to help people with low credit or no credit secure access to credit and loans.
With the shortage of shipping containers and truck drivers, the global supply chain is taking a beating just ahead of the holiday season. As retailers gear up to meet higher demand, DHL Express is adding capacity, both in infrastructure and aviation. Greg Hewitt, U.S. CEO at DHL Express, joined Cheddar's Opening Bell to provide some additional details on the ramped-up investments.
Electric vehicle startup Rivian is disrupting the auto industry following its record-breaking public debut on Wednesday taking it to a higher market value than legacy automakers Ford and General Motors. Thomas Speidel, CEO at fast battery-charging firm ADS-Tech Energy, joined Cheddar to talk about what the IPO means for the broader development of electric vehicles in the U.S. He also talked about the pressure Ford faces after its gas-powered F-150 had been the best-selling vehicle in the U.S. for nearly 45 years.
Moderna is defending its COVID-19 vaccine after a study found an increase in reports of myocarditis, which is an inflammation of the heart, in males ages 12 to 29 — about 13.3 cases in every 100,000 subjects. The pharmaceutical giant said the benefits of the vaccine outweigh the risk of the possible negative side effect.
